The Evidence Research Unit has changed to Complete Market Access

For over 10 years, the Evidence Research Unit has been providing research and materials to pharmaceutical clients around the world to help them communicate with payers at both an international and domestic level. Originally established in response to the growing emphasis on healthcare cost containment, the Evidence Research Unit evolved to help companies demonstrate the value of their products as they approached the market.

Now, in recognition of the changing emphasis on market access and the need to support products throughout their lifecycle, often for a variety of indications and patient populations, we have changed our name to Complete Market Access. As the barriers to the adoption and uptake of new pharmaceuticals become ever greater, Complete Market Access will continue to provide a range of innovative market access solutions, from evidence-based value demonstration, to pricing and reimbursement initiatives.

Complete Market Access is part of Complete Medical Group